Category: Press Release

• Showstoppers Global 7500 and Challenger 3500 aircraft on display present outstanding performance attributes, technological advancements, sustainability aspects and exceptional, pristine cabins for maximum productivity and comfort
• On-site Bombardier Defense and Bombardier leadership presence reveals the expansive aircraft capabilities of our highly specialized business jets
• Exclusive customer visits of Global 7500 and Challenger 3500 aircraft available by appointment

MONTRÉAL, Nov. 08, 2023 (GLOBE NEWSWIRE) — Bombardier today announced that its industry-leading Global 7500 and Challenger 3500 aircraft will be on display during the Dubai Air Show Nov. 13-17 in Dubai, UAE revealing the uncompromising attributes of these impressive business jets. Bombardier is also pleased to share that it will have a strong presence on site, with dedicated sales teams from business aircraft and Bombardier Defense.

“We are pleased to be bringing the uncompromising Challenger 3500 and Global 7500 aircraft to the Dubai Air Show this year, celebrating the Global 7500’s recent 150^th built aircraft and impressive new speed records*,” said Éric Martel, Bombardier’s President and Chief Executive Officer. “The Middle East is an important market for Bombardier both for business jet customers as well as growing defense business. The Bombardier team on site will proudly showcase our impressive defense capabilities and the many multi-mission solutions we can flexibly tailor. We also look forward to showcasing our Challenger and Global platforms to business jets customers, who will benefit from our aircraft cutting-edge innovation, cabin design, performance, reliability and smooth ride.”

With a top speed of Mach 0.925 and a range of 7,700 nautical miles (14,260 km), the Global 7500 aircraft possess unmatched performance capabilities, boasts the smoothest ride in the skies and has transformed the industry with its refined, luxurious cabin.

Like the Global 7500, Bombardier’s Challenger aircraft possess industry-leading attributes that set it apart from its competition. Bombardier’s Challenger 3500 aircraft combines a world-class interior design with the ultimate value proposition. It boasts the widest in-class cabin and lowest direct operating costs in its class, making this business aircraft a consistent winning option with customers.

The Defense sales team will also be on hand to highlight Bombardier’s portfolio of proven and versatile aircraft platforms, including the Global 6500 jet. Bombardier Defense has more than 500 specialized business aircraft in-service worldwide with more than 3 million fleet hours and some 160 operators in more than 50 countries. The Challenger and Global aircraft families provide the ideal solution for urgent humanitarian assistance, VIP transportation, Maritime Patrol, Electronic Warfare, Search and Rescue and more. For customers or media interested in exploring the aircraft on display, visits are available by appointment.

About Bombardier

Bombardier (BBD-B.TO) is a global leader in aviation, focused on designing, manufacturing, and servicing the world’s most exceptional business jets. Bombardier’s Challenger and Global aircraft families are renowned for their cutting-edge innovation, cabin design, performance, and reliability. Bombardier has a worldwide fleet of approximately 5,000 aircraft in service with a wide variety of multinational corporations, charter and fractional ownership providers, governments, and private individuals. Bombardier aircraft are also trusted around the world in government and military special-mission roles leveraging Bombardier Defense’s proven expertise.

Headquartered in Greater Montréal, Québec, Bombardier operates aerostructure, assembly and completion facilities in Canada, the United States and Mexico. The company’s robust customer support network services the Learjet, Challenger and Global families of aircraft, and includes facilities in strategic locations in the United States and Canada, as well as in the United Kingdom, Germany, France, Switzerland, Italy, Austria, the UAE, Singapore, China and Australia.

For corporate news and information, including Bombardier’s Environmental, Social and Governance report, as well as the company’s plans to cover all its flight operations with Sustainable Aviation Fuel (SAF) utilizing the Book and Claim system visit bombardier.com. Learn more about Bombardier’s industry-leading products and customer service network at businessaircraft.bombardier.com. Follow us on Twitter @Bombardier.

Bombardier, Bombardier Global, Global 6500, Global 7500, Challenger and Challenger 3500 are registered or unregistered trademarks of Bombardier Inc. or its subsidiaries.

*All records are pending final approval by the National Aeronautic Association (NAA)

For Information
Matthew Nicholls
Bombardier
+ 1 514-243-8214
matthew.nicholls@aero.bombardier.com

GlobeNewswire Distribution ID 8974581

Mont-Saint-Guibert, Belgium – November 7, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Jefferies London Healthcare Conference, which takes place November 14 – 16, 2023 in London.

Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver a corporate update on Wednesday, November 15, 2023, at 5:00pm GMT. A webcast of the presentation will be available on the Events section of Nyxoah’s Investor Relations website. The Company will also be available for 1×1 meetings with institutional investors attending the event.

Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

• ENGLISH_Nyxoah to Participate in the London Healthcare Conference_FINAL

GlobeNewswire Distribution ID 1000898171

Dover, DE, Nov. 07, 2023 (GLOBE NEWSWIRE) — Pacific Green Technologies, Inc. (“Pacific Green”, OTCQB: PGTK) announces that it has entered into a transaction to sell 100% of the shares in Pacific Green Battery Energy Parks 2 Limited (“PGBEP2”) to Sosteneo Fund 1 HoldCo S.à.r.l. (“Sosteneo HoldCo”) for £210 million (US$258 million) (the “Transaction”).

PGBEP2 is the holding company for 100% subsidiary, Sheaf Energy Limited, Pacific Green’s 249 MW / 373.5 MWh battery energy storage system in Kent, England (“Sheaf Energy Park”), which will begin commercial operations in July 2025.

Sosteneo HoldCo is an investment vehicle for the Sosteneo Energy Transition Fund, managed by Sosteneo SGR S.p.A. (“Sosteneo”), a specialist manager of greenfield infrastructure projects related to the energy transition and part of the Generali ecosystem of asset management firms.

Under the terms of the Transaction, Pacific Green and Sosteneo have granted each other respective options to buy or sell the shares in PGBEP2.

As part of the Transaction, Sosteneo will provide a capital expenditure loan, which together with the senior debt facility, will fully fund the development and construction of Sheaf Energy Park.

About Pacific Green Technologies, Inc.:

Pacific Green is focused on addressing the world’s need for cleaner and more sustainable energy. Pacific Green offers Battery Energy Storage Systems and Concentrated Solar Power to complement its environmental technologies division. Pacific Green has offices in the USA, Canada, United Kingdom, Australia, Saudi Arabia and China.

For more information, visit Pacific Green’s website:
www.pacificgreen.com

Notice Regarding Forward-Looking Statements:

This news release contains “forward-looking statements,” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the continued development of Sheaf Energy Park, the continuation of the Transaction, any potential business developments and future interest in Pacific Green’s battery, solar and environmental technologies.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the continuation of the development of Sheaf Energy Park, the continuation of the Transaction and general economic and political conditions. These forward-looking statements are made as of the date of this news release, and Pacific Green assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although Pacific Green believes that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in Pacific Green’s annual report on Form 10-K for the most recent fiscal year, Pacific Green’s quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Scott Poulter, Chairman & CEO
Pacific Green Technologies
T: +1 (302) 601-4659

GlobeNewswire Distribution ID 8974156